School of Medicine
Showing 1,511-1,520 of 4,925 Results
-
Anne Elizabeth Goldring, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Goldring is a board-certified, fellowship-trained physiatrist with Stanford Health Care Orthopaedics and Sports Medicine. She is clinical assistant professor in the Department of Orthopaedic Surgery, Division of Physical Medicine and Rehabilitation, at Stanford University School of Medicine. Dr. Goldring completed a Physical Medicine and Rehabilitation (PM&R) residency at Northwestern University in Chicago, followed by fellowship training in Sports and Spine at the Hospital for Special Surgery in New York.
Dr. Goldring’s clinical practice focuses on the non-operative management of musculoskeletal injuries and spine disorders. She specializes in delivering comprehensive care for a range of conditions, including sports-related injuries, osteoarthritis, neck, and back pain. She is focused on optimizing patient function, with the goal of helping patients return to their desired activities and prevent future injury. She believes that movement is medicine and wants to help patients achieve active, healthy lifestyles. She provides guidance throughout a physical rehabilitation course with personalized physical therapy prescriptions and exercise plans. When necessary, she also offers more aggressive interventions like injection therapies or surgical referrals. Her practice includes the use of diagnostic electromyograms (EMGs), ultrasound-guided musculoskeletal injections, shockwave therapy, Ortho biologics, such as platelet rich plasma (PRP), and fluoroscopic-guided lumbosacral spine injections.
Dr. Goldring has published articles in PM&R, Journal of Surgical Research, and The Physician and Sportsmedicine. She has delivered presentations and lectures all over the nation, including in Chicago, New Orleans, and New York. Her research and presentations, have covered topics ranging from women’s sports medicine, improving medical education curriculum, ergonomic interventions in the workplace, and the impact of intensive lifestyle medicine programs on musculoskeletal pain.
Dr. Goldring is a member of the American Medical Society for Sports Medicine, American Academy of Physical Medicine and Rehabilitation, Association of Academic Physiatrists, and Spine Intervention Society. She has provided sideline coverage at multiple athletic events, including the Bank of America Chicago Marathon, the Long Island Nets basketball, and United Soccer League (USL) games. -
Mary Kane Goldstein
Professor of Health Policy, Emerita
Current Research and Scholarly InterestsHealth services research in primary care and geriatrics: developing, implementing, and evaluating methods for clinical quality improvement. Current work includes applying health information technology to quality improvement through clinical decision support (CDS) integrated with electronic health records; encoding clinical knowledge into computable formats in automated knowledge bases; natural language processing of free text in electronic health records; analyzing multiple comorbidities
-
Andrea Goldstein-Piekarski
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)
BioDr. Goldstein-Piekarski directs the Computational Psychiatry, Neuroscience, and Sleep Laboratory (CoPsyN Sleep Lab) as an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and PI within the Sierra-Pacific Mental Illness Research, Education and Clinical Center (MIRECC) at the Palo Alto VA. She received her PhD in 2014 at the University of California, Berkeley where she studied the consequences of sleep on emotional brain function. She then completed a Postdoctoral fellowship at Stanford focusing on understanding the brain basis of anxiety and depression.
As the director of the CoPsyN Sleep Lab she is developing a translational, interdisciplinary research program that combines human neuroimaging, high-density EEG sleep recording, and computational modeling to understand the neural mechanisms through which sleep disruption contributes to affective disorders, particularly depression, across the lifespan. The ultimate goals of this research are to (1) develop mechanistically-informed interventions that directly target aspects of sleep and brain function to prevent and treat affective disorders and (2) identify novel biomarkers which can identify which individuals are most likely to experience improved mood following targeted sleep interventions.
This work is currently supported by The KLS Foundation, a R01 from National Institute of Mental Health, and a R61 from the National Institute of Mental Health. -
Natalia Gomez-Ospina
Assistant Professor of Pediatrics (Genetics)
Current Research and Scholarly InterestsDr. Gomez-Ospina is a physician scientist and medical geneticist with a strong interest in the diagnosis and management of genetic diseases.
1) Lysosomal storage diseases:
Her research program is on developing better therapies for a large class of neurodegenerative diseases in children known as lysosomal storage disorders. Her current focus is on developing genome editing of hematopoietic stem cells as a therapeutic approach for these diseases beginning with Mucopolysaccharidosis type 1 and Gaucher disease. She established a genetic approach where therapeutic proteins can be targeted to a single well-characterized place in the genome known as a safe harbor. This approach constitutes a flexible, “one size fits all” approach that is independent of specific genes and mutations. This strategy, in which the hematopoietic system is commandeered to express and deliver therapeutic proteins to the brain can potentially change the current approaches to treating childhood neurodegenerative diseases and pave the way for alternative therapies for adult neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease
2) Point of care ammonia testing
She also works in collaboration with other researchers at Stanford to develop point-of-care testing for serum ammonia levels. Such device will greatly improve the quality of life of children and families with metabolic disorders with hyperammonemia.
3) Gene discovery
Dr Gomez-Ospina lead a multi-institutional collaboration resulting in the discovery of a novel genetic cause of neonatal and infantile cholestatic liver disease. She collaborated in the description of two novel neurologic syndromes caused by mutations in DYRK1 and CHD4.
For more information go to our website:
https://www.gomezospina.com/
